<SEC-DOCUMENT>0001213900-24-069347.txt : 20240815
<SEC-HEADER>0001213900-24-069347.hdr.sgml : 20240815
<ACCEPTANCE-DATETIME>20240815073617
ACCESSION NUMBER:		0001213900-24-069347
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20240815
FILED AS OF DATE:		20240815
DATE AS OF CHANGE:		20240815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Scinai Immunotherapeutics Ltd.
		CENTRAL INDEX KEY:			0001611747
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37353
		FILM NUMBER:		241210636

	BUSINESS ADDRESS:	
		STREET 1:		JERUSALEM BIOPARK, 2ND FLOOR
		STREET 2:		HADASSAH EIN KEREM CAMPUS
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			00000
		BUSINESS PHONE:		972-8-9302529

	MAIL ADDRESS:	
		STREET 1:		JERUSALEM BIOPARK, 2ND FLOOR
		STREET 2:		HADASSAH EIN KEREM CAMPUS
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BiondVax Pharmaceuticals Ltd.
		DATE OF NAME CHANGE:	20140624
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0211529-6k_scinai.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Report of Foreign Private Issuer Pursuant to Rule
13a-16 or 15d-16</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Under the Securities Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">For the Month of August 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Commission File Number: 001-37353</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SCINAI IMMUNOTHERAPEUTICS LTD.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Jerusalem BioPark, 2nd Floor</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Hadassah Ein Kerem Campus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Jerusalem, Israel</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Indicate by check mark whether the registrant files
or will file annual reports under cover Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Form 20-F &#9746;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Form 40-F &#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; background-color: white"><B>Explanatory Note</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">On August
15, 2024, Scinai Immunotherapeutics Ltd. issued a press release announcing publishing of Q2 2024 financial results and providing a business
update.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">A copy of
the press release is furnished herewith as Exhibit 99.1.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">This Report
on Form 6-K is hereby incorporated by reference into the registrant&rsquo;s Registration Statements on Form S-8&nbsp;(File No.&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1611747/000121390023030288/ea176534-s8_biondvaxpharma.htm">333-271293</A>&nbsp;and
File No.&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1611747/000121390020015429/ea123060-s8_biondvaxpharma.htm">333-239344</A>) and&nbsp;Form F-3&nbsp;(File No.&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1611747/000121390023068963/ea183844-f3_biondvaxpharma.htm">333-274078</A>&nbsp;and File No.&nbsp;<A HREF="http://www.sec.gov/Archives/edgar/data/1611747/000121390024007939/ea192382-f3_scinaiimmun.htm">333-276767</A>), to be a part thereof from
the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exhibit Index</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1.5pt solid; width: 9%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit&nbsp;No.</B></FONT></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 90%; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify"><A HREF="ea021152901ex99-1_scinai.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Press release dated August 15, 2024.</FONT></A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Scinai Immunotherapeutics Ltd.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 36%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: August 15, 2024</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1.5pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Amir Reichman</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amir Reichman</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">2</P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea021152901ex99-1_scinai.htm
<DESCRIPTION>PRESS RELEASE DATED AUGUST 15, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: justify; margin: 0"><B>Scinai Publishes Q2 2024 Financial Results and Provides Business Update; Restructures $29 Million Bank Loan to
Equity; On Track to Regain Nasdaq Compliance by August 23</B></P>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">JERUSALEM,&nbsp;Aug. 15, 2024&nbsp;/PRNewswire/ --&nbsp;<B>Scinai
Immunotherapeutics Ltd.</B>&nbsp;(Nasdaq: SCNI) (&ldquo;Scinai&rdquo;, or the &ldquo;Company&rdquo;), a biopharmaceutical company focused
on developing inflammation and immunology (I&amp;I) biological products and on providing CDMO services through its Scinai Bioservices
business unit, today published its financial results for the quarter ended June 30, 2024 and provided a business update. The Company will
hold a webinar covering its Q2 2024 financial results and business update on August 20<SUP>th</SUP>&nbsp;at 11AM EDT/18:00 Israel time.
Registration for the webinar can be done using the following&nbsp;LINK.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ex99-1_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Business Update &amp; Recent Highlights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Conversion of EIB Loan into Equity and Regaining Nasdaq Compliance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 7, 2024, the Company announced that on June 5, 2024, it had
received formal notification from the Listing Qualification Department (the &ldquo;Staff&rdquo;) of the Nasdaq Stock Market (&ldquo;Nasdaq&rdquo;)
that the Company remains non-compliant with the requirement in Listing Rule 5550(b)(1) that a company have stockholders&rsquo; equity of at
least $2.5 million, or any of the alternative requirements under Nasdaq Listing Rule 5550(b) (&ldquo;Equity Requirement&rdquo;). &nbsp;Accordingly,
on June 18, 2024, the Company presented its plan to regain compliance with the Equity Requirement with the Nasdaq Hearing Panel. The plan
presented to the panel included a debt-to-equity loan restructuring deal between the Company and the European Investment Bank (the &ldquo;EIB&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On July 3, 2024, the Company announced that the Hearings Panel had
determined to grant the Company&rsquo;s request to continue its listing on The Nasdaq Stock Market, subject to the Company meeting certain conditions,
including filing on or before August 14, 2024 a public disclosure demonstrating compliance with the Equity Requirement. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On August 13, 2024, the Company announced that it had signed a Loan
Restructuring Agreement, which included an amendment and restatement to the amended Finance Contract with the EIB. The closing of the
transaction is subject to delivery of customary closing documents and is expected to close by August 23, 2024. In connection with the
transaction, an amount equal to approximately EUR 26.6&nbsp;million (equal to approximately $29&nbsp;million), including interest accrued
to date, owed by the Company to the EIB under the amended Finance Contract between the parties will be converted into 1,000 preferred
shares, no par value per share, of the Company (the &ldquo;Preferred Shares&rdquo;) convertible into ADSs. Following such conversion, the
total outstanding amount owed by the Company to the EIB will be EUR 250,000 (equal to approximately $273,000). The outstanding amount
will have a maturity date of December&nbsp;31, 2031, will not be prepayable in advance, and no interest accrues or is due and payable
on such amount.&nbsp; Under the terms of the agreement, EIB may not convert its Preferred Shares into ADSs for a period of twelve (12)
months from the date of issuance of the Preferred Shares.&nbsp; In addition, EIB may not convert its Preferred Shares into ADSs if at
the time of conversion the aggregate number of ADSs EIB will receive or would have been entitled to receive within the twelve months prior
to such conversion would exceed 4.99% of the ADSs issued and outstanding at the time of such conversion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On August 14, 2024<SUP>h</SUP>&nbsp;the Company received from the Nasdaq
Hearing Panel an extension until August 23, 2024 to close the restructuring transaction with the EIB and thereby demonstrate compliance
with the Equity Requirement. Following closing of the restructuring transaction with the EIB, the Company intends to issue a press release
submitted on Form 6-K stating that as a result of the completed loan restructuring, the Company has stockholders&rsquo; equity above $2.5 million
as of the date of the filing. .</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CDMO business unit</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Since Jan 2024, the Company has received CDMO work orders valued at
approximately $600K, and the Company is in advanced contract discussions with several other potential clients. The Company maintains confidence
in its sales guidance for 2024 of $1.25 million in expected revenues. As the Company &nbsp;CDMO unit is new, and the Company is focused
on rapidly growing, acquiring new clients and building its reputation and brand awareness of its CDMO services, the Company expects revenues
from the CDMO business to increase materially in the coming years. This is also coupled with growing demand for boutique CDMO services
from early-stage biotech companies looking for fast project onset at competitive pricing without compromising on meeting the most stringent
scientific and quality standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In addition, in 2024 the Company has been pursuing extensive targeted
marketing activities, including online advertisements, direct outreach campaigns and participation in major pharmaceutical conferences,
such as BIO Europe Spring in Barcelona (March 2024), and the BioMed Israel conference in Tel Aviv, Israel (May 2024), at which the Company
marketed its CDMO services and met&nbsp;potential partners for its R&amp;D pipeline and potential investors. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s CDMO unit is currently focused both on executing drug
development projects for its clients and on validating its processes and facilities to be ready for cGMP inspection by the Israeli Ministry
of Health.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In June 2024, the Company held its first of its kind, hands on aseptic
processing course at its facility in Jerusalem in collaboration with key figures in the industry including Ms. Rachel Shimonovitz, Head
of GMP inspectorate of the Israeli Ministry of Health, and ADRES Int&rsquo;l Biotech, a leading Israeli regulatory and quality consulting services
firm. The course attracted many senior role holders from the Israeli biotech industry who came to the Company&rsquo;s facility for this two-day
education and training course.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Pipeline Development</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company is aggressively advancing the NanoAb preclinical development.
At the end of April 2024, the Company concluded an in-vivo proof of concept animal study in collaboration with Prof. Amos Gilhar, a world-renowned
dermatologist of the prestigious Technion Israel Institute of Technology.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On July 15, 2024, the Company announced promising results as the statistical
analysis of psoriasis markers measured in the study confirmed that the effect of Scinai&rsquo;s NanoAb was similar to that of the two comparator
drugs, supporting the hypothesis that intralesional injection of a nanoAb blocking the IL-17 cytokine can positively impact the inflammatory
cytokine cascade, and lead to reduction in psoriatic lesion severity and improvement of the skin&rsquo;s integrity. By delivering a biological
treatment directly into psoriatic lesions, the Company aims to improve disease management for patients suffering from mild to moderate
plaque psoriasis by offering the high potency and specificity advantages reserved for biologic drugs while providing a safer and more
convenient treatment option compared to existing therapies currently offered to this patient category.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On June 4, 2024, the Company met for a scientific advisory meeting
with the Paul Erlich Institute (the PEI) of Germany, the scientific advice of which is considered acceptable guidance for IMPD filing
with the European Medicines Agency (EMA) and is also considered the European comparable to a pre-IND meeting with the FDA in the U.S.
&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Consequently, on July 23, 2024, the Company announced the receipt of
positive regulatory feedback from the PEI for its drug development program towards Phase 1/2a clinical trial of its anti-IL-17A/F nanoAb
(SCN-1) in Plaque Psoriasis. The minutes of meeting clarified its preclinical toxicology and clinical program for Plaque Psoriasis with
intralesional injections for the treatment of patients with mild to moderate Plaque Psoriasis. The PEI requested to see data of efficacy
in blocking IL-17F, and this data became available as per the Company&rsquo;s announcement on July 15, 2024 describing the positive in vivo
proof of concept results. The PEI accepted the Company&rsquo;s position that toxicology studies can be conducted in pigs rather than in Non-Human
Primates. The PEI also accepted the Company&rsquo;s position to compare the SCN-1 to placebo directly in patients with mild to moderate plaque
psoriasis while skipping the need for testing in healthy volunteers, resulting in a phase 1/2a clinical trial, which will assess both
safety and efficacy in the same trial. Moreover, the PEI agreed to compare SCN-1 to placebo on the same human subject, a strategy that
could significantly reduce the number of patients required for the clinical trial. Last, the PEI commented that the manufacturing process
looks well developed and that controls and specifications presented are acceptable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Phase 1/2a study is expected to include approximately 24 plaque
psoriasis patients and is expected to commence in the second half of 2025 with readout in 2026. &nbsp;&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additional NanoAbs for treatment of additional autoimmune diseases,
such as asthma, atopic dermatitis and wet AMD, have been discovered and characterized at Max Planck and University Medical Center G&ouml;ttingen
as part of their research collaboration agreement with Scinai. Scinai holds exclusive options for exclusive licenses at pre-agreed financial
terms for each of the resulting NanoAbs.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company is pursuing strategic partnerships and sublicensing options
for both its COVID-19 self-administered inhaled NanoAb, which demonstrated highly promising in vivo results in animals as both a therapeutic
and prophylactic treatment, and its anti-IL-17 nanoAb for the treatment of plaque psoriasis and other potential indications.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Q2 2024 Financial Summary</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>R&amp;D expenses</B>&nbsp;for the six months ended June 30,
2024 amounted to $2,788 thousand, compared to $3,449 thousand for the six months ended June 30, 2023. The decrease was primarily due
to a reduction in salaries and reduced use of subcontractors.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Marketing, general and administrative expenses</B>&nbsp;for
the six months ended June 30, 2024 amounted to $1,003 thousands, compared to $2,332 thousands for the six months ended June 30, 2023.
The decrease was primarily due to a reduction in salaries, share-based compensation and professional services.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Financial expenses&nbsp;</B>for the six months ended June
30, 2024 amounted to $526 thousand compared to $1,496 thousand for the six months ended June 30, 2023.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>Net loss</B>&nbsp;for the six months ended June 30, 2024
was $4,481 thousand compared to net loss of $7,277 thousand for the six months ended June 30, 2023.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of June 30, 2024, the Company had cash and cash equivalents
and short-term deposits of $3,076 thousands compared to $4,870 thousands as of June 30, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>U.S. dollars in thousands</B> &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">June 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">December&nbsp;31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>ASSETS</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>CURRENT ASSETS:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left; padding-left: 9pt">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">3,076</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">4,870</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt">Restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">138</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">140</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt">Trade receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">119</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Prepaid expenses and other receivables</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">324</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">437</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 2pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total current assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,657</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,447</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 2pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">NON-CURRENT ASSETS:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt">Property, plant and equipment, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,180</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">10,825</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 9pt">Operating lease right-of-use assets</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,014</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,200</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 2pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total non-current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,194</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12,025</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 2pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt; padding-left: 0pt">Total assets</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">14,851</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">17,472</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are an integral part of the financial statements.&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>U.S. dollars in thousands (except share data)</B> &nbsp; &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">June 30,</TD><TD STYLE="font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold">December&nbsp;31,</TD><TD STYLE="font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">LIABILITIES NET OF CAPITAL DEFICIENCY</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">CURRENT LIABILITIES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-indent: -0.125in; width: 76%; text-align: left">Trade payables</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">658</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">535</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Operating lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">364</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">396</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Other payables</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">650</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">849</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Total current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,672</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,780</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">NON-CURRENT LIABILITIES:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Warrants liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">96</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-indent: -0.125in; text-align: left">Loan from others</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,820</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">19,368</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Non-current operating lease liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">640</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">797</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Total non-current liabilities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">20,463</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">20,261</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">SHAREHOLDERS&rsquo;&nbsp;DEFICIT:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">Ordinary shares of no par value: Authorized: 20,000,000,000 shares at June 30, 2024 and at December 31, 2023; Issued and outstanding 3,349,431,584 shares at June 30, 2024 and 1,857,169,984 shares at December 31, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Additional paid-in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">121,272</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">119,506</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Accumulated deficit</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(126,816</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(122,335</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Accumulated other comprehensive loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,740</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(1,740</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Total shareholders&rsquo; deficit</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(7,284</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(4,569</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 4pt">Total liabilities and shareholders&rsquo; deficit</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">14,851</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">17,472</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are an integral part of the financial statements. </P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>STATEMENTS OF OPERATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>U.S. dollars in thousands (except share data)</B></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">For the six months ended<BR>
 June 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; width: 76%; padding-left: 0.125in">Revenues</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">284</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-bottom: 1.5pt; padding-left: 0.125in">Cost of revenues</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">448</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Gross loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(164</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Research and development expenses, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,788</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,449</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Marketing, general, and administrative expenses</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,003</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">2,332</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Total operating expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,791</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,781</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Total operating loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">3,955</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,781</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Total Financial Expenses net,</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">526</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,496</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-bottom: 4pt; padding-left: 0.125in">Net loss</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">4,481</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">7,277</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-bottom: 4pt; padding-left: 0.125in">Net loss per share attributable to ordinary shareholders, basic and diluted</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.002</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">(0.006</TD><TD STYLE="padding-bottom: 4pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-bottom: 4pt; padding-left: 0.125in">Weighted average number of shares used in computing net loss per share attributable to ordinary shareholders, basic and diluted</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">2,288,278,248</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">1,322,019,241</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are
an integral part of the financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>STATEMENTS OF COMPREHENSIVE</B>&nbsp;<B>LOSS</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>U.S. dollars in thousands</B> &nbsp; &nbsp; &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">For the six months ended<BR>
 June 30</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Net loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">4,481</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">7,277</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Other comprehensive income:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Foreign currency translation adjustments</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(267</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 4pt">Total comprehensive loss</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">4,481</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">7,010</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are an integral part of the financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>STATEMENTS OF CHANGES IN SHAREHOLDERS&rsquo; EQUITY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>U.S. dollars in thousands (except share data)&nbsp;</B> &nbsp;</P>



<P STYLE="margin: 0">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt; padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Ordinary shares</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional<BR>
 paid-in</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated<BR>
 comprehensive</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Total<BR>
 shareholders&rsquo;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">capital</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">loss</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">deficit</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">equity</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt; padding-left: 0.125in; text-indent: -0.125in; width: 28%">Balance as of January 1, 2024</TD><TD STYLE="padding-bottom: 4pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: right; width: 1%">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; width: 9%; text-align: right">1,857,169,984</TD><TD STYLE="padding-bottom: 4pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; width: 9%; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="padding-bottom: 4pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; width: 9%; text-align: right">119,506</TD><TD STYLE="padding-bottom: 4pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; width: 9%; text-align: right">(1, 740</TD><TD STYLE="padding-bottom: 4pt; width: 1%; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; width: 9%; text-align: right">(122,335</TD><TD STYLE="padding-bottom: 4pt; width: 1%; text-align: left">)</TD><TD STYLE="padding-bottom: 4pt; width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; width: 9%; text-align: right">(4,569</TD><TD STYLE="padding-bottom: 4pt; width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Issuance and exercise of warrants, net of issuance costs of $275(see note 5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,491,240,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,433</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,433</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Vested RSU&rsquo;s</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,020,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">333</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(4,481</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(4,481</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">Balance as of June 30, 2024</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,349,431,584</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">121,272</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(1, 740</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(126,816</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(7,284</TD><TD STYLE="text-align: left">)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Ordinary shares</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Additional<BR>
 paid-in</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated<BR>
 comprehensive</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Accumulated</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; font-weight: bold; text-align: center">Total<BR>
 shareholders&rsquo;</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">capital</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">loss</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">deficit</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">equity</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; width: 28%; padding-bottom: 4pt">Balance as of January 1, 2023</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; width: 9%; text-align: right">989,290,784</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; text-align: right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; text-align: right">116,082</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; text-align: right">(2,007</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; text-align: right">(115,835</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">)</TD><TD STYLE="width: 1%; padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 4pt double; text-align: right">(1,760</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">Exercise of warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">464,015,200</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">801</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">801</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Vested RSU&rsquo;s</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">664,800</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Reclassification of warrants liability to equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">398</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">398</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Share-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">459</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">459</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left">Other comprehensive income</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">267</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">267</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt">Net loss</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(7,277</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(7,277</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">Balance as of June 30, 2023</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,453,970,784</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">117,740</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(1, 740</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(123,112</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(7,112</TD><TD STYLE="text-align: left">)</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>STATEMENTS OF CASH FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>U.S. dollars in thousands</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">For the six months ended<BR>
 June 30,</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center; font-weight: bold; border-bottom: Black 1.5pt solid">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1.5pt"><U>Cash flows from operating activities:</U></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 76%; text-align: left">Net loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(4,481</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">(7,277</TD><TD STYLE="width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Adjustments to reconcile net loss to net cash used in operating activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Depreciation of property, plant and equipment</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">652</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">285</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Financial expense related to loan from others</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">451</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,321</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>Revaluation of warrants</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(93</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,333</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Share-based compensation</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">333</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">452</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Decrease (increase) in receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(119</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Decrease (increase) in other receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">110</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">8</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Changes in operating lease right-of-use assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">189</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(16</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Increase in trade payables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">125</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(31</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Changes in operating lease liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(189</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Increase (decrease) in other payables</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(199</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(347</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net cash used in operating activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(3,221</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(5,935</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline; text-align: left">Cash flows from investing activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Purchase of property, plant and equipment</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(8</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(383</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1.5pt">Net cash used in investing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(8</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(383</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are an integral part of the financial statements.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>STATEMENTS OF CASH FLOWS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>U.S. dollars in thousands</B></P>



<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended<BR>
 June 30,</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2024</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in; padding-bottom: 1.5pt"><U>Cash flows from financing activities:</U></TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-left: 0.125in; text-indent: -0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; width: 76%; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Proceed from exercise of warrants, net</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">1,433</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Net cash provided by financing activities</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">1,433</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Effect of exchange rate changes on cash, cash equivalents and restricted cash</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">121</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">(265</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Increase (decrease) in cash, cash equivalents and restricted cash</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(1,917</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(6,583</TD><TD STYLE="text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Cash, cash equivalents and restricted cash at beginning of year</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">5,010</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">14,215</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-bottom: 4pt; padding-left: 0.125in">Cash, cash equivalents and restricted cash at end of year</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,214</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">7,632</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-decoration: underline; text-indent: -0.125in; text-align: left; padding-left: 0.125in">Supplementary disclosure of cash flows activities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-left: 0.125in">(1) Cash paid during the year for:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-bottom: 4pt; padding-left: 0.125in">Interest</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">143</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">725</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-left: 0.125in">(2) Non-cash transactions:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Reclassification of warrants liability to equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">398</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-bottom: 4pt; padding-left: 0.125in">Exercise of warrants liability into shares</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">-</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">801</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-decoration: underline; text-indent: -0.125in; text-align: left; padding-left: 0.125in">Reconciliation of cash, cash equivalents and restricted cash:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-left: 0.125in">Cash and cash equivalents</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">3,076</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">7,506</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-bottom: 1.5pt; padding-left: 0.125in">Restricted cash</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">138</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">126</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; text-align: left; padding-bottom: 4pt; padding-left: 0.125in">Cash, cash equivalents and restricted cash</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">3,214</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">7,632</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The accompanying notes are an integral part of the financial statements.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Scinai Immunotherapeutics</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical
company with two complementary business units, one focused on in-house development of inflammation and immunology (I&amp;I) biological
therapeutic products beginning with an innovative, de-risked pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large
unmet medical needs, and the other a boutique CDMO providing biological drug development, analytical methods development, clinical cGMP
manufacturing, and pre-clinical and clinical trial design and execution services for early stage biotech drug development projects.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Company website:&nbsp;www.scinai.com.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>This press release contains forward-looking statements within the
meaning of the Private Litigation Reform Act of 1995. Words such as &ldquo;expect,&rdquo; &ldquo;believe,&rdquo; &ldquo;intend,&rdquo; &ldquo;plan,&rdquo;
&ldquo;continue,&rdquo; &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;anticipate,&rdquo; and similar expressions are intended to identify forward-looking
statements. All statements, other than statements of historical facts, are forward-looking statements. Examples of such statements include,
but are not limited to, the closing of the transaction with EIB, ability of the Company to regain and remain compliant with the continued
listing standards of Nasdaq, the potential of Scinai&rsquo;s NanoAb program, expected revenues of Scinai&rsquo;s CDMO business and timing of pre-clinical
and clinical studies of the Company&rsquo;s anti-IL NanoAbs for the treatment of plaque psoriasis and their results. These forward-looking statements
reflect management&rsquo;s current views with respect to certain current and future events and are subject to various risks, uncertainties and
assumptions that could cause the results to differ materially from those expected by the management of Scinai Immunotherapeutics Ltd.
Risks and uncertainties include, but are not limited to; risk associated with the closing of the transaction with EIB; the risk that the
Company will otherwise be unable to regain compliance and remain compliant with the continued listing requirements of Nasdaq; lower than
anticipated revenues of Scinai&rsquo;s CDMO business in 2024 and thereafter; failure to sign agreements with other potential clients of the
CDMO business; a delay in the commencement and results of pre-clinical and clinical studies, the risk of delay in, Scinai&rsquo;s inability
to conduct, or the unsuccessful results of, its research and development activities, including the contemplated in-vivo studies and a
clinical trial; the risk that Scinai will not be successful in expanding its CDMO business or in-license other NanoAbs; the risk that
Scinai may not be able to secure additional capital on attractive terms, if at all; the risk that the therapeutic and commercial potential
of NanoAbs will not be met or that Scinai will not be successful in bringing the NanoAbs towards commercialization; the risk of a delay
in the preclinical and clinical trials data for NanoAbs, if any; the risk that our business strategy may not be successful; Scinai&rsquo;s ability
to acquire rights to additional product opportunities; Scinai&rsquo;s ability to enter into collaborations on terms acceptable to Scinai or
at all; timing of receipt of regulatory approval of Scinai&rsquo;s manufacturing facility in Jerusalem, if at all or when required; the risk
that the manufacturing facility will not be able to be used for a wide variety of applications and other vaccine and treatment technologies;
and the risk that drug development involves a lengthy and expensive process with uncertain outcomes. More detailed information about the
risks and uncertainties affecting the Company is contained under the heading &ldquo;Risk Factors&rdquo; in the Company&rsquo;s Annual Report on
Form 20-F filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) on May 15, 2024, and the Company&rsquo;s subsequent filings with
the SEC. Scinai undertakes no obligation to revise or update any forward-looking statement for any reason.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Photo:&nbsp;https://mma.prnewswire.com/media/2482084/Scinai_Immunotherapeutics.jpg<BR>
Logo:&nbsp;https://mma.prnewswire.com/media/2310190/Scinai_Immunotherapeutics_Logo.jpg</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="ex99-1_002.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Company Contacts&nbsp;<BR>
</B>Investor Relations | +972 8 930 2529 |&nbsp;ir@scinai.com<BR>
Business Development | +972 8 930 2529 |&nbsp;bd@scinai.com&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">12</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #1 9 # 2(  A$! Q$!_\0
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M2L'CCNPLX4CH0PR0?RKHYY)69YJI4_:)[6>W3[S!\$00OXHN+^W1$EFL]KJ
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MJ"X]>@JC+>7$HP\K8].@J.5620[SECR:CJ&S.4Y-B@T&DIP.:$R!AHI325+
M=BDHHI %%%!-  :;114@%%%% !1FBB@ S2YI*7-,!:,TE&:H!U%)FEH *2E
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M>,X3GD]N<<U80[E4X(R,X/44 <S_ ,*S\"_]"O9_^/?XT?\ "L? O_0L6?\
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@K3:** $/6FT44 (>M--%% #333UHHH :::>M%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" "E 4L# 2(  A$! Q$!_\0
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MUW^S[#35N-.^(/C[2)O-N;V[;R8[WP=X:QE5>W5+B'Q W)(N-/"G!;=]\?\
M!3G]IU_V9/V<[^3P_J2Z?\1?B/?-X0\&7*;3=Z&EU&(_$7C*%2IROA31KJ2X
M?#(1)>6Y.1D#^/>76C(KJ7E7<C+<S[_])C7SYKMFN(_^6F+,111CMB3UJ,4J
MLJ,Z=-.,GRVFDVU%23T5E\2YKZ[?C^U^!WA[0SODXESG#)X##5YI4JD>:$U&
M,U*JZDK1M2?+**Y)7E&5VGRM>L0:A/<SPV5L)9[F>?9;6$=M]KO);B\<""U:
MU_Y:WT\BO@_P.2?XB:_5/]G;_@EG\;/BSI]AXG^)6JVWP=\,7\<%Q!INI6+:
MOXWOK:?S&$ZZ4V+72E1%C: 7#C[0+G(&(#GZ?_X)3_L0:1I/A[1OVF/BKI<-
M]XLU]8M8^&'AO4K"$Z=X6\-72L=+\1&S)<SZUK,:+<:;=2+&]C#;RRP$O=AX
M_P!W[ !5D3:%=6_>XD,Q:7<ZL\DVQ=TS*JAXN?)"H@PI7/'3RK"S2GB:;J3M
M??EWTUOS:];?B?3^)/C?F669I7X:X#Q<LOR_+(JA5Q^%J0524XVC*-*#HSA#
MWDX2DY337,HI/WC\F/#_ /P2 _9NL+;R-;\1_%W7]05$\_4O^$GTG1H+@D,5
M:#2].TN8QH.<I<.2,C83^\QP/Q!_X(V_##4+&YF^&'Q5\<>%-91)3;Q^)[:'
MQ9I$LK!3!#<I:Q:%JUG#N5UENK'4U4(X>>UO#'"B_MI2$9(/I_\ 6_PK1Y3E
MLERSPL7'KKO;57LN]OGJ?BL/%/Q%IU:E:?%^<XF4YQGR5:U%4U::DTHPH0:3
M2MI*-^MTVC^,#]H;]E#X\?LQW9?X@^&7OO"+71MX/'GA%AK?A&Y!9 IN);B#
M3M6TZ=Q(GF6VHZ7 %8L+:^U$1RO!;_8PTK]H+Q5\=?#T7[.FI3:+XLL[J"?7
M_$ 3S/"&F>#X[NW;4K?QW%UG\/:M&-K:0@+ZIJ%I9[03:BO[!/&GA?0_&.BW
MOAKQ+I.G:[H6M6MS9:GI&L6D=_IFHVDJKYMG-:2.%>X929[254=X&MY)%,9&
MZO(?V=_V;/A'^S5X7U7PC\)/#BZ%INKZG-K.JW<TB7.J:S>7#33QW-Y?@"2>
MTMA<S6VF0,B):1"98P?-9B1RNA3FGAFZ4$[\EN9^BE>*^=MM[L_2,7X^YEF/
M"N+R/-<LP>/Q6*PWU.5>O.,W-U)1@J[C/#RFI4U^]<%4:G)*,90C>2]FL%O(
M[=+>]DBGO5M[1;FZ@C9+:YG,40GF1&'^CM),CL+'>[6MJ;0,P$BBOY)?^"DV
ML);?MK?&I1)+$([_ ,(31M!_K_,@\%>'3$L?T?#/SQL'6OZ[I$Q'&H/]\'_O
MW(../>OXTO\ @I[JGD_MO?'>'/W+CP3_ ./?#SPIZ?3W_'BM,?AJE:A:-1J4
M'!*T;W2DKZ<RZ+IIOH</T?JM%\:YW/$T?K,:F4+ *GS^SI156K!.HX.,U))5
M)6IV5I*+4URI+]F_^"57[77C?XQZ+XE^$?Q#:+7=9^&6C:/J>C>+_P#EYO=&
MU"74K.#2;Q<X\S14LH(DDX9TO"K$B.,#]D1+&DLFW),(568D<Y:!F]1D>?D?
M\"Z8 K^:K_@AS>?:_B_\=/\ IG\.O!?_ (]XBO?_ (G\\U_2]'RTW^^G_I-!
M6^%C*E0492;FU;F:M>S2V]$UJ^M^A\9XKY?ALHXVSG+\LHQPU**]K-12M5G7
MA)MJ*24.6<^>R=GRM)1YFS\'_P#@L7\(_'NL#X<?&7PYI$NL^#O!WA_7O#?B
M2722!?Z$]_J&FS6.H7JDY;1 8KU=3*9""* -M.!7X.Z)XYU_P9KFA>)?".K7
MFA^)=$U&QOM$UK0?EDTN]B=I(M8@'2[T><KLN=*Q_P 3 )_T[U_=7KVDV&M:
M==:5J5G;W^GZA:75A>VEW;?;;:\L[Q5BN;*YM-KK);W,3%)G<;$"@,"KD'^6
MS_@HS_P3TU?]G:^U+XR?"'3[J_\ @W?7;WFMZ-8Q?;]4^&]_<2Q'SY%8[KKP
M9=O//M4[O[&%DREF^UJS<>)R^E-_68/EKQ?NRU;5W9M;-IPO'?1[]#]=\&_$
MS*UD>$X#XE5)X1RKPA.HXJ%=5*=1PIRA.#]G.%9QG\<E45[<LN9/]<_V"/V^
M/#G[36BQ>"O%\NEZ%\;="L@=6TJ*Y2WL?&-K9J8;CQ-X<0;6^T2!(Y]>TDAF
MT9[BQ._R[P!/TZMMI+,"2TD<,A+#YMK>845F_B*C/<D9.2<Y/^?AX<\?ZSX+
MU_2/%OA#7;WP_P"(=!U"#6M"U[091<R6FHQL)(-8@O<_Z?H\A5DN="_Y;+\O
M/EFOZO/^">__  4,\,_M3:!;^!O'$VF>'_CMH>GVESK&CPR)%IWC:Q@2>*;Q
M/X;4%1#<2"VBEUW2?F;27N+$ ^7=JJ=6&E-J-*2;DT[SNU>RYOA:M=M=&KMW
MWT?R7BKX58GAK$3SC(L,ZN3X_P#VF4:<&XTH3ES)J47-^RBI7NU:"23]RSI_
MJ[4<G;\?Z5FI<*Q5F4_O5650SEW5)!E PY '!P!GN"3C%71SG'0;?U!/'M@5
MTSA.,4XRY6[-.UU:]GI?Y=+;]#\&IUJ-:52G%MSHRM5@TXN,D[6WZ27;I\CR
MOXX%1\'OBFP^]'\/?&;_ %"^&M4)XYZ8]/QK^'2VUW:L"_W/LPZ'/-M:<?4D
M?H17]Q7QZ^7X)_%YASL^&GCC]/"^J?K@&OX([;6MD<40[P6XSGTM[3\?\\G
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MVGZG?:=?Z/>7UA87MYH^IW%A<:AHUU=VZW,^CZD^F2R69U/3O.2WOFA:Y1Y
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MACX _P#'_%U[[G^Y7]=3GY?^ ?\ LX'\C_DU_'9_P;:7GVO]H#]I;_IG\)_
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MM.8KI.G_ !'TNR\(:M#>>*/#MJ0/L&LPK!;S>,/"P+OX>;4-%NTQ!K4<</\
M'U9ZPOEV,JNS!H8W4.AWHC6T053(/]8 4?:1TR?[W'%6'B?5M#U&TU?1]1_L
MW5[5VO;*ZM+O;=P-<P/;FRMA_P MK;[/+<7,-Y_R\M=R*,^3QF+K6QDVRRR1
M1V\L$!GF\ZY:+S9;AY)N3M\RXN;@ICKANXQ7T^"R>5.E6J1BIPE&4FU&WV7;
MK*_3LO(_3^&.%L+PM7SG,<N:A@\ZP]::P\8Q4;*C5FG&I&3]UOEFHN'NVM%V
M>G^C=_P3(F\_]@/]E67^]\(O#3>O\$H_D/UK[J9MKD>J,?\ OE0?\_2O@?\
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MBU_\._@XD7Q6^(C2X.GW0T-I%\&>'KY6)#1:SXO?3;N=/XM/T741C)X^RP.
M6$RRKBZJ7+*,9)-<MN:45NV[ZM:VZ[']0<!8>CP'X:RSC&I?6L93J5I5VE1J
M1]LO94X1B^=S=IPBGS1NY:Z*Y_8=_P $T?V98_V4OV1OAK\/M0LVM?&NKV;>
M._B(DJ_Z1#XX\:Q6^N:QIDQ(Y_X1U;FW\/(>A32PP^]7WE=0K,GE;(I&8/\
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M.\;)15_BNF[ORLN]SQ?$;'X/-.)L7C\)7C4H5(635FK*E.+=T^GIU['\9O\
MP<ZWGV3]H7]EC_II\'OB!_XYXRLNO_?7IUQ7PK_P0>U'[1_P4U^!D6!\W@[X
MR_I\-==/'_UN_P"./UT_X. /V&?VMOVJ_CC^SWXF_9R^"FN_%3P]X2^&/C/P
M[XDO]$U3PQIQTO4;_P 1Z?=6<-X/$?B7P]YC7*071@%I]KV"VD:<6ZRV_G_'
M?_!';_@F[^W=^S_^W_\ !_XK?&S]G7QE\//AMH'ACXG:7J'BF_U_P#<VEG?:
MWX+U'1=-BEMM-\2>(KR47+7\ZJ(5M6)3"BX)Q#]?@JN6_P"I]3"3QD(8RE&-
M2G3<$W4:JQE*-^=--0BWHI/2UC]/RWB+)H>$T<J>-I_7X4JD:="\>:HZM1J6
MG/S1Y(2E/X9<W(XJU[K^WD?ZQA[ _G_^JI0< CU_^O\ XU3@ VQE54;TCE;8
MIV,S@Y=9 !%)N"@GRR<<$GYUJ[$,-)[[3_Z%7YE\4JZ=U:22?>SLGZ:7]&?S
MO"/+[:%_@JRDI6^)2D]$NFCT=WZ"[#[?Y_"N>\2V%AK&EWVA:O9V&HZ7K%A?
M6&H6&IVZWNGW-G/$L5Q#J%J^8Y=/FA=[>[9P5C$R;L*21TU0R@':#P?FQ^E2
MO;1:=.I:46G%./9IZ.]T]-'Z$N+B_:4[QJ1E&<91;3O&2E?1KM_6A_##_P %
M@_\ @D9JW[*NI:]^TI^SOH&JWO[-^MZA->^/O!^E0G5K_P" MYJ4L3W=_I-@
MW-U\/;RZ<O!J!)/A 22KN=-461OYZEUL@ ,<R2))YB&7S#;@*IBM8Q_RTME@
M:*Y@O/\ EZ-W*I_U%?ZR.O:/8ZWIEWH>JZ?9ZII>L6=[I6HV6H6D5]I]Q8WU
MI-%<PZG:RNL=WIES'FUO+217CG$\?F;40M7\4G_!3/\ X(%_&#P?\45^('[!
M?@6_\>?"SQ[J5\VJ_!W3-:T;3M>^$6M7L-U/>MX2N/$.IZ+IMQX,O;BX!L-"
MN-7LAX<+W,:&<:CN7],X7XBHJE+!9BU3<J=5*K*2:ERTIRBK-+5R27Q=>Z:?
M]"^'GB?SX2659]7_ (>&Q%/#XBI5TBHX:HHQDI)<TI645[RYKW7O)J7]-W_!
M*%Q)_P $Z?V2']?@MX8/YK./\:U/^"EG[5EM^QI^Q[\7_C5%-:CQ9;>'[SPK
M\-M/NCA=7^(WBF*2P\,V@&T[HK*07.O7RDK_ ,2W1KUMV5 ,W_!.7X9>/_A%
M^Q!^S-\.?B3X:O?!?Q$\&?"3PGI?BCPG>WNGSOX?UN."(76C74GAO7M0T:6X
MBC$$[*NL:B ]RREHLRQ/^)__  7N^!7[?'[7GCOX1?"7]G']GSQOX^^"OPML
M+WQSK?B'1]?\%:9IWBCXG>)?M&EZ"%&M>,M(NIX_ OAVS1Q*\;OO\1RLXCWH
M&^4PE'#8S/VJ]2-/!2Q%2<ZK2E'ECSS@K.45[TXQBGS:7NKGY;@:.7YEQ?5>
M(QD*&7U<=B*E7$2@IQC!3J5HIQE4@GSSC&%^=6OS:G\>>I^(9;V\OM1U&\N=
M3N]3N+G5+O4;F'SI+V34)WUJZNV_NSZ@ LE_U!U&:\[#%?WT?\$$OV3C^S]^
MQKIWQ.\2V0M?B#^TM?6GQ0U93 838^!X_P"T;;X6Z20#\RMX>O+CQ6#Q@^,'
M'O7\O?[-G_!$?]O7QO\ 'KX3^$/C=^SWXN^'GP;U+QWH;_$WQSJ'BCX?7D=A
MX)TA;2^\5 PV'B3Q'=-<:]IFDW_A^Q$:VK_;]3M& N,?N/\ 0Q\+:3I_A_1M
M/T'2=/M]*TO1]/T_3M,TRSB\JTT[3;"TCL+"PMMO[EH;.WM$M[?R@NVT2V#*
M/E+?1<89AA52P^!RZO&5+V:C/DM9\MFKI-VU5[7Z??\ H_BOQ3@J^6Y)P[E&
M-C6P>'I)8A47%1K<D8R@I1A.2@U*//9RE\*T5T;*H"^X'.3VZ' .?\\>]#9W
MCL3G/X?X9-6::RY(]!U_2OSN'-24I2?.V^W+HWZOJ[ON?@W(HIQ@N5.2;ZWM
M)2:Z;I6^?4XCQUX4\.>/O"OB#P/XMTVUU;PUXMT/5_#FOZ;=JIAO]#UW2KS2
M]9T^0L/]1J.F7=W87>THQL[FX 8'K_F%_M:_ [7?V4?VC_B[^SOXGEN)[CX;
M>+]5T;2=2N?]=XA\'W=E]K\ ^)N.ESXD\+:QH=_J [:F;L<$5_J074:NR[C@
M >9N]!%+!*1]#Y8R?2OY</\ @OK_ ,$Q?C9^TUXS^#_[0G[+GPTN_B%\2DLM
M0^%OQ/T#3M3TC3KQ_#D/FZOX,\40OK&I:=;R-X>^W>*K4@&;9_;BA]I8;_K.
M#L=1P.-5'&5$L-B.?GJ2LE2?).<'RM^]S2M#XH_S>3_5?"OBFGPYG5:GCJJ6
M7YE3G2E*4U".#DJ51QJ)--5>>WLVFZ:CSJ5]&I?$_P#P;J_MAMX%^/?C+]E'
MQ3JL@\+_ !VTJ;Q;X%@O?]78?%OPC81MXA\.PDX 'BGP=;:C?-D,2?"T:C&X
MD?VN0E2DP"H-R&;>N,7'G1*[7 5?NHTC21*&R?W1(., ?YQ?PT_X)=?\%</A
M%\0O _Q8\ _LG^.M)\9_#[Q?H/CGPG=S>)_A%OLM1\.W&GW4&D316GCJPO9;
M6]BLKJUO!+:W[#3M8O0BP%F\[_0_^'FO:YXJ\">$?$_B/POJ7@/7]?\ #.B:
MSJW@W6Y;6YU+P??ZA8V5]>^&M2N;!38M>Z#+--IEW(LLL;:C;WGDE41@=>,:
M>"6.H5\!5A7ISE!SY4HK=*[M*>R:?_;O=G/XHT,F><X?&Y3C*6+ABY0J594X
M1A[.?-%N_+4J<R<=)/W=8IVZ'^?U_P %Q-2^S_\ !3W]IV+CY4^$?IGGX*?#
ML_S/_P"O.*^Z/^#9R\^U_M7_ +1/_3/]GS2./]_XB>'/T^7BN,_X*X_\$T_V
M\OCQ_P %!/C_ /%KX-?LW>,/'OPY\5)\.3X9\4:=XE\ 6-I?)HOPH\#>'M82
M&WU'Q-X?NT,/B/2=8#";[6XW#*VV0LWV)_P0$_82_;#_ &5?VC?C9XR_:-^"
M7B7X4^&O%?P6TWPSX?U;5]:\,:LFHZW%XVT/56L(CX=\2^(?LQ%K9,THO/L?
MG!T%OYXCG,'T.98O+EPQ&$,5&>*5'#16'48W;52@IKFYW;EBI2?N]+:;GZ)G
M'$>2U_"VGE%/'4WCZ%#!*-"\7*I)8G".HK*;<?9PC.3TDWRVLM6OZT%^Z/J_
M_HQZL+T'T'\JH0*,2-@99@ 2H$BQ%!*D4G?,;S2[5Y"A_4FG;&]/U%?F$8I2
MDW*W,V]N[O8_FNK4=.;M'FN[[VW^3+U03;3M!."=V/\ QW-3TU@".<\9/%-J
M+TDKQZJ]O,U:BTU)73W5[>FOD[,J*C+T;OW)/Z=/PIK*)3@$93J2H.<^G!].
MU6#MR,9SSUQ[=*0'!;!ZXS^&1_G\:PG4AS*$%-1M[TH2<>7>W3J[+?J9TX1I
MJ2C*H]?BC*4>2[T7NM[[7*Q@'?RCZ90?ITIT:K&W&P;O[B@9P1U_/CIWYJR<
MX&??KUQQU_7K42E<MM.>F?;KQ6L8Q23E4J2_N3FVG\KZVWVZ%J46^252MS/:
M+JS:EUZ]EKUV' @L>2<8R>_5O\_U-3KMYP,>O^<FFQ]_P_K1)V_'^E+EAS)P
MC:6O5_/IV"3C"-]4ENV[O5V7YDE0S;OEV_[7I[>M,(!ZBFG:N..OX]/J:O;X
MTE'K>_RZ+J4I04>?F32Z.-]]-GYO]1Z;A[GZ=.O<<\^V*9-&7V].,_>&[KCI
ME>.G.,]JDC<<X![?U]ZE!."2,#MZ^_\ GBLW"DWS1NNJE&337?5::^?0AU'+
M6*:7\T&X/Y-:^OS10\@_['_? _PI0AC_ +O/HH'3\/>K6Z/=C!SZ8X]?\]O:
MGDJ<$@\YQ_G-"C_+5JMKHZCDOFDQ-N2M"I7;VUJS:7JKZ_>BL5./F; ]!_\
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M@G:7-HTKW3B_E<M4*+RNM6YTJL%3M#E3<KU81=IJ=TTFW9P=TMT?OQ;#@M@
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510 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
